Undiagnosed Appalachian Gene Mutation Poses Extreme Lung Cancer Threat to Never-Smokers

The mutation, identified through whole-exome sequencing of 4,200 never-smoker lung adenocarcinoma cases and matched controls, shows 3.8% carrier frequency in Eastern Kentucky and West Virginia populations versus 0.1% nationally. Carriers developed cancer at median age 52 with predominantly EGFR-wildtype tumors exhibiting high tumor mutational burden. Observational data indicate that standard low-dose CT screening criteria based on smoking history would miss 87% of these cases.

Related studies in Nature Genetics and JAMA Oncology have documented founder effects for other high-penetrance alleles in isolated Appalachian communities, including variants linked to hereditary breast cancer and cardiomyopathy. The current finding extends this pattern, revealing that geographic genetic isolation can concentrate cancer-risk alleles at frequencies rivaling BRCA1 in Ashkenazi populations. Absence of routine cascade testing leaves relatives unaware of their elevated risk.

Next steps require prospective validation through a multi-center registry and development of targeted screening protocols. Without intervention, modeling projects an additional 1,200 preventable cases annually in the affected region by 2035.

Public health agencies must integrate regional ancestry into risk algorithms rather than relying solely on smoking exposure metrics.